Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal L24 domain containing 1 pseudogene 3 (RSL24D1P3) is a human pseudogene related to the ribosomal L24 domain containing 1 (RSL24D1) gene. Pseudogenes like RSL24D1P3 typically lack protein-coding potential due to mutations or genomic rearrangements, and are not known to function as therapeutic targets, receptors, enzymes, or drug-interacting proteins. While some pseudogenes have been observed to play regulatory roles at the RNA level, such as competing for microRNAs or modulating gene expression, there is no specific evidence for functional activity or disease association of RSL24D1P3 itself[1][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal L24 domain containing 1 pseudogene 3 (RSL24D1P3).